Plexus (Nasdaq: PLXS ) is expected to report Q3 earnings on July 18. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Plexus's revenues will improve 8.5% and EPS will increase 8.6%.
The average estimate for revenue is $606.8 million. On the bottom line, the average EPS estimate is $0.63.
Last quarter, Plexus recorded revenue of $573.5 million. GAAP reported sales were 0.9% higher than the prior-year quarter's $568.1 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.56. GAAP EPS of $0.56 for Q2 were 5.1% lower than the prior-year quarter's $0.59 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 9.5%, 30 basis points worse than the prior-year quarter. Operating margin was 4.5%, 10 basis points worse than the prior-year quarter. Net margin was 3.5%, 70 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $2.33 billion. The average EPS estimate is $2.36.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 353 members out of 374 rating the stock outperform, and 21 members rating it underperform. Among 88 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 84 give Plexus a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Plexus is hold, with an average price target of $38.13.
Over the decades, small-cap stocks, like Plexus have provided market-beating returns, provided they're value priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.
- Add Plexus to My Watchlist.